Pivot Park Screening Centre (PPSC) will be attending the SLAS 2023: Innovation Accelerated Symposium.
Our CTO, Steven van Helden, PhD, our CSO, Saman Honarnejad, PhD and our Business Development Director, Geert Belgraver, MBA, will be present to inform you about the latest developments at Pivot Park Screening Centre.
Sunday February 26th, at 10:30 AM PST
“Automated, Label-Free MALDI-MS-Based Cell assays: from Feasibility Study to High-Throughput Screening”
Our CTO, Steven van Helden, PhD, will be present this short course together with Björn C. Fröhlich and Stefan Schmidt from CeMOS. During the course the possibilities of MALDI-based cell assays for screening and profiling of drugs will be discussed.
Wednesday March 1th, at 1 PM PST
“Evaluating target engagement of a focused lead-like and pan-assay interference compound collection using affinity selection mass spectrometry”
Want to meet with us while we are there? Schedule your appointment with our experts here directly!